U.S. Healthtech Stock News

Yum! Brands (NYSE:YUM) plans to spin off its Pizza Hut business as part of a broader transformation strategy. The company is initiating the closure of 250 U.S. Pizza Hut locations, affecting its domestic footprint. The announcement signals a potential reshaping of Yum! Brands' brand mix and capital allocation priorities. Yum! Brands runs a global portfolio of quick service restaurants, and Pizza Hut has long been one of its core banners alongside KFC and Taco Bell. The decision to separate...

If you are wondering whether Deckers Outdoor is fairly priced or offering value right now, this article will walk you through what the current share price could mean for you as an investor. The stock closed at US$114.51 recently, with a 7.2% year to date return but declines of 3.1% over the last week, 4.0% over the last month, and 16.6% over the last year. These sit alongside a 58.5% 3 year and 116.8% 5 year return. Recent coverage has focused on Deckers Outdoor as a long term compounder in...

Bright Horizons Family Solutions (BFAM) has come under pressure after reporting weaker fourth quarter 2025 results, including sizeable impairment and lease termination costs tied to center closures and a sharp increase in expected facility shutdowns for 2026. See our latest analysis for Bright Horizons Family Solutions. The weaker quarter, higher 2026 closure plans and fresh legal investigations have come on top of a tough run for the stock, with a 30 day share price return of 19.17% and a 1...

Antero Resources (AR) has been drawing attention after recent share price moves, with the stock closing at $37.08. For investors, the key question is how this performance lines up with the company’s fundamentals. See our latest analysis for Antero Resources. The recent 7 day share price return of 9.06% has added to a steadier backdrop, with the 90 day share price return at 6.80% and the 1 year total shareholder return at 2.57%, suggesting momentum has picked up over the short term compared...

Hycroft Mining Holding (HYMC) has drawn fresh attention after filing an independent Technical Report that updates its Mineral Resource estimate, incorporates higher gold and silver price assumptions, and highlights progress toward potential commercial operation. See our latest analysis for Hycroft Mining Holding. The Technical Report lands after a sharp shift in sentiment, with Hycroft Mining Holding’s share price returning 380.93% over 90 days and a very large 1 year total shareholder...

International Paper (IP) is in the middle of a major reshaping, closing its Georgetown container plant and preparing to split into separate North America and EMEA companies, while reallocating capital toward newer packaging assets. See our latest analysis for International Paper. Those portfolio moves sit against a share price of US$42.89, with a 90 day share price return of 13.32% and a 1 year total shareholder return decline of 19.17%. This suggests momentum has picked up recently even as...

In late February 2026, FIGS, Inc. reported fourth-quarter 2025 revenue of US$201.9 million and net income of US$18.51 million, capping a full-year performance of US$631.1 million in sales and US$34.25 million in net income with sharply higher earnings per share versus 2024. Management paired these results with an outlook for 10% to 12% revenue growth in 2026, underscoring momentum from a larger active customer base, international expansion and improved operating margins. We’ll now examine...

In late February 2026, California Water Service Group reported that fourth-quarter 2025 sales eased to US$219.98 million and net income fell to US$11.48 million, with full-year 2025 sales of US$1,000.14 million and net income of US$128.21 million, reflecting lower water consumption and higher costs. At the same time, the company accelerated its expansion by agreeing to acquire Nexus Water Group’s Nevada and Oregon systems and the remaining interest in its Texas joint venture, while...

Aardvark Therapeutics recently voluntarily paused its Phase 3 HERO trial of ARD-101 for hyperphagia in Prader-Willi Syndrome, and no longer expects to report topline data in the third quarter of 2026, with updated guidance now planned for the second quarter of 2026. The pause affects Aardvark’s lead asset in a rare disease setting where ARD-101 already holds both Orphan Drug and Rare Pediatric Disease designations from the FDA. We will now examine how the pause of the HERO Phase 3 trial for...

Newmont (NEM) is back in focus after a cluster of upbeat analyst calls linked to stronger gold sentiment, the agenda of its new CEO, and recent results featuring record free cash flow and near zero net debt. See our latest analysis for Newmont. Recent news around stronger free cash flow, buybacks and a higher fourth quarter dividend has arrived alongside a 42.27% 3 month share price return and a very large 1 year total shareholder return. This suggests momentum has been building rather than...

Hawaiian Electric Industries reported full-year 2025 revenue of US$3.09 billion, down slightly from US$3.22 billion in 2024, while swinging from a very large net loss to net income of US$123.12 million, or US$0.71 in basic and diluted earnings per share from continuing operations. The earnings rebound coincided with progress on Maui wildfire-related settlements, funded by insurance, and regulatory approval of a multi-year wildfire safety plan that supports both risk reduction and grid...

If you are wondering whether Enpro's current share price really reflects its underlying worth, this article walks through what the numbers actually say about value. Enpro's share price recently closed at US$264.05, with returns of 10.6% over 30 days, 20.5% year to date, 49.2% over 1 year, 155.4% over 3 years and 205.4% over 5 years. These figures may catch the eye of investors thinking about future risk and reward. Recent coverage around Enpro has focused on its role within the capital goods...

Why AES (AES) is on investors’ radar today AES (AES) is drawing attention after a mixed run in its share price, with a 1 day return of around 0.18% and a past 3 months total return of about 1.79%. Over the past year, the stock’s total return of roughly 34.25% contrasts with weaker multi year figures. At the same time, annual revenue of about US$12.1b and net income of roughly US$1.1b frame the current debate around valuation and business momentum. See our latest analysis for AES. That sharp 1...

Why Rayonier’s latest dividend move is drawing fresh attention Rayonier (RYN) has drawn fresh attention after its board set the first quarter cash dividend at $0.26 per share, a trim from $0.2725, following a December special dividend and recent shifts in short interest. See our latest analysis for Rayonier. For context, Rayonier’s share price now sits at US$21.64, with a 1 day share price return of 0.70% and a 90 day share price return of 0.98%. The 1 year total shareholder return of 11.76%...

Recently, GLOBALFOUNDRIES Inc. reported that short interest as a share of its freely tradable float fell 6.2%, to 12.7%, still well above the 4.53% average for peers. This decline suggests a shift in sentiment even as the company remains one of the more heavily shorted names among comparable semiconductor foundries. We’ll now explore how this reduction in short interest fits into GlobalFoundries’ broader investment narrative and evolving risk-reward profile. The future of work is here...

Public Service Enterprise Group (PEG) has drawn fresh attention as investors reassess its recent share performance, with the stock showing mixed short term moves but positive returns over the past month and past 3 months. See our latest analysis for Public Service Enterprise Group. The recent pullback, including a 1 day share price return of 1.82% decline to US$84.50 and a softer 7 day share price return of 2.10% decline, comes after steadier gains. The 30 day and 90 day share price returns...

In late February 2026, Zscaler reported second-quarter results showing revenue rising to US$815.75 million while its net loss widened to US$34.31 million, and the company raised both third-quarter and full-year fiscal 2026 revenue and annual recurring revenue guidance. At the same time, Zscaler’s higher spending in a competitive market and concerns around billings, new customer growth, and integration of acquired businesses have led investors to question how durable its growth and path...

UFP Technologies (NasdaqCM:UFPT) amended its manufacturing supply agreement with Intuitive Surgical. The amendment extends the term of the partnership between the two companies. Minimum volume commitments under the agreement were increased. A new program for additional products was added to the supply arrangement. For you as an investor, this centers on UFP Technologies' role as a specialized manufacturer for the medical device sector, supplying components and solutions to a leading global...

If you are wondering whether Modine Manufacturing's current share price actually lines up with its underlying worth, you are not alone. This article is going to focus squarely on what the numbers say about value. The stock last closed at US$238.50, with returns of 7.2% over 7 days, 29.2% over 30 days, 69.4% year to date and 209.2% over 1 year, while the 3 year return is very large and the 5 year return is around 15x. Recent news around Modine Manufacturing has largely centered on its role in...

Earnings, guidance and new buyback put Expro Group Holdings (XPRO) in focus Expro Group Holdings (XPRO) is back on investors’ radar after releasing fourth quarter and full year 2025 results, setting 2026 revenue guidance, and unveiling a new US$100 million share repurchase plan. The latest numbers give you a fresh look at how the business ended 2025. The guidance and buyback outline how management is thinking about the next phase. Here is what stands out from the announcement and how you...

Harrow (NasdaqGM:HROW) has introduced a new Direct-to-Prescriber PharmaPack offering focused on post-cataract surgery care. The PharmaPack kits provide access to FDA-approved ophthalmic products and are designed to be ordered directly by eye care providers. The launch aims to reduce reliance on off-label compounded formulations and support more standardized treatment protocols. For investors following ophthalmic therapeutics, Harrow sits at the intersection of branded eye care drugs and...

In February 2026, Blue Owl Capital Inc. filed a US$615.5 million shelf registration for 50,000,000 Class A shares linked to an employee stock ownership plan, shortly after restricting withdrawals from a fund and planning to sell US$1.40 billion of assets across three funds to repay debt and return capital to investors. These moves, including the permanent removal of a quarterly withdrawal option in its smallest vehicle, highlight how Blue Owl is balancing growth ambitions with tighter...

Savara Inc. recently announced that the FDA has accepted for review its Biologics License Application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and granted the therapy Priority Review, with a PDUFA action date set for August 22, 2026. The drug’s combination of Priority Review, Fast Track, Breakthrough Therapy, Orphan Drug, Innovation Passport, and Promising Innovative Medicine designations highlights both its potential clinical importance and the high...

If you are wondering whether Truist Financial's current share price really lines up with its underlying worth, this article will walk through the key numbers that matter most. Over the short term, the stock has seen a 1.1% decline over 7 days and a 3.6% decline over 30 days. The longer term picture shows a 14.3% return over 1 year, 26.4% over 3 years, and 5.1% over 5 years from a last close of US$49.55. Recent market attention around large US banks has kept Truist Financial in focus,...